Grown Rogue International Inc. (CSE: GRIN)
GRIN trades on the Canadian Securities Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for GRIN.CN, last bar 2026-11-13, computed by MarginsX. Website: sociallinks: 10-K text ("our website").
Profile
| Field | Value |
|---|---|
| Ticker | GRIN on the Canadian Securities Exchange |
| Yahoo symbol | GRIN.CN |
| Sector | Life Sciences, Drug Manufacturers—Specialty & Generic |
| Headquarters | Ontario |
| Listed | The TMX list gives no listing date |
| Listing type | TMX leaves listing type blank for long-listed issuers |
| Shares outstanding | 249,938,980 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001463000 |
| Website | www.grownrogue.com |
Returns
| Window | Return |
|---|---|
| 1 day | +9.5% |
| 1 week | +10.6% |
| 1 month | -7.1% |
| 3 months | -18.8% |
| 6 months | +6.1% |
| Year to date | -25.7% |
| 1 year | +9.5% |
| From 52-week high | -25.7% |
| 52-week range | C$0.3800 to C$0.7000 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
178 documents in 12 types. Each title links to the document at its source.
Interim financial statements (3)
| Document | Type | Filed |
|---|---|---|
| UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND SIX MONT | Interim financial statements (6-K) | 2025-08-13 |
| Unaudited Condensed Consolidated Financial Statements Period 2025-03-31 | Interim financial statements (6-K) | 2025-08-01 |
| Unaudited Condensed Interim Consolidated Financial Statements Period 2024-09-30 | Interim financial statements (6-K) | 2024-11-15 |
MD&A (2)
| Document | Type | Filed |
|---|---|---|
| FMANAGEMENT DISCUSSION & ANALYSIS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 20 | MD&A (interim) (6-K) | 2025-08-13 |
| MANAGEMENT DISCUSSION & ANALYSIS Period 2025-03-31 | MD&A (interim) (6-K) | 2025-08-01 |
Material change report (2)
| Document | Type | Filed |
|---|---|---|
| Form 51-102F3 | Material change report (6-K) | 2025-04-15 |
| Form 51-102F3 | Material change report (6-K) | 2024-11-15 |
News release (25)
| Document | Type | Filed |
|---|---|---|
| NEWS RELEASE DATED NOVEMBER 12, 2026 | News release (8-K) | 2026-11-13 |
| NEWS RELEASE DATED OCTOBER 22, 2026 | News release (8-K) | 2026-10-23 |
| NEWS RELEASE DATED OCTOBER 20, 2026 | News release (8-K) | 2026-10-21 |
| NEWS RELEASE DATED OCTOBER 20, 2026 | News release (8-K) | 2026-10-20 |
Management information circular / proxy (2)
| Document | Type | Filed |
|---|---|---|
| DEF 14A | Proxy statement (DEF 14A) | 2026-09-04 |
| PRE 14A | Proxy statement (PRE 14A) | 2026-08-21 |
Prospectus (3)
| Document | Type | Filed |
|---|---|---|
| PRELIMINARY SHORT FORM BASE SHELF PROSPECTUS | Prospectus (base shelf) (6-K) | 2025-04-10 |
| F-1/A | Prospectus (long form) (F-1/A) | 2025-02-13 |
| F-1 | Prospectus (long form) (F-1) | 2024-12-13 |
Annual report (3)
| Document | Type | Filed |
|---|---|---|
| 20-F Period 2024-12-31 | Annual report (20-F) (20-F) | 2025-04-30 |
| 10-K/A Period 2025-12-31 | Annual report (10-K) (10-K/A) | 2026-05-01 |
| 10-K Period 2025-12-31 | Annual report (10-K) (10-K) | 2026-04-08 |
Quarterly report (3)
| Document | Type | Filed |
|---|---|---|
| 10-Q Period 2026-09-30 | Quarterly report (10-Q) (10-Q) | 2026-11-13 |
| 10-Q Period 2026-06-30 | Quarterly report (10-Q) (10-Q) | 2026-08-05 |
| 10-Q Period 2026-03-31 | Quarterly report (10-Q) (10-Q) | 2026-05-12 |
Early warning / ownership (4)
| Document | Type | Filed |
|---|---|---|
| Schedule 13D | Schedule 13D (SCHEDULE 13D) | 2025-07-01 |
| Schedule 13G amendment | Schedule 13G (SCHEDULE 13G/A) | 2026-06-08 |
| Schedule 13G amendment | Schedule 13G (SCHEDULE 13G/A) | 2026-04-17 |
| Schedule 13G amendment | Schedule 13G (SCHEDULE 13G/A) | 2026-04-15 |
Insider report (37)
| Document | Type | Filed |
|---|---|---|
| Form 3 | Form 3 (3) | 2026-06-26 |
| Form 3 | Form 3 (3) | 2026-06-26 |
| Form 3 | Form 3 (3) | 2026-06-26 |
| Form 3 | Form 3 (3) | 2026-06-26 |
Certification (20)
| Document | Type | Filed |
|---|---|---|
| EXHIBIT 32.2 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-13 |
| EXHIBIT 31.1 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-13 |
| EXHIBIT 31.2 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-13 |
| EXHIBIT 32.1 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-13 |
Other (74)
| Document | Type | Filed |
|---|---|---|
| FORM 8-K | Current report (8-K) (8-K) | 2026-11-13 |
| FORM 8-K | Current report (8-K) (8-K) | 2026-10-23 |
| FORM 8-K | Current report (8-K) (8-K) | 2026-10-21 |
| FORM 8-K | Current report (8-K) (8-K) | 2026-10-20 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
Trading: the last notice, on 2026-08-21, was a resumption.
| Notice | Action | Reason | Notice |
|---|---|---|---|
| 2026-08-21 9:45 AM ET | Resumption | No reason stated | CIRO notice |
| 2026-08-21 8:38 AM ET | Halt | Pending News | CIRO notice |
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Recent
| Date | Time | Event | Webcast | Source |
|---|---|---|---|---|
| 2026-11-12 | 5:00 p.m. Eastern Time | Q3 2026 earnings call | Webcast | SEC filing |
| 2026-11-12 | after the market closes | Q3 2026 earnings release | No webcast link announced | SEC filing |
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2023-08-23 | Equity, Debt, Option To Acquire, Security To Be Acquired, Other | US$1.0M | US$1.6M | SEC EDGAR |
| 2023-07-18 | Equity, Debt, Option To Acquire, Security To Be Acquired, Other | US$4.0M | US$6.4M | SEC EDGAR |
| 2022-12-12 | Debt, Option To Acquire, Security To Be Acquired, Other | US$1.9M | US$3.0M | SEC EDGAR |
| 2018-11-29 | Equity, Option To Acquire | US$22.5M | US$22.5M | SEC EDGAR |
| 2012-05-02 | Equity, Other | US$750K | Open-ended | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| EBM | Eastwood Bio-Medical Canada Inc. | TSXV | C$130.9M | -7.4% | +133.3% |
| HLS | HLS Therapeutics Inc. | TSX | C$136.2M | -8.4% | -21.9% |
| COV | Covalon Technologies Ltd. | TSXV | C$122.3M | +3.4% | +122.8% |
| JUSH | Jushi Holdings Inc. | CSE | C$111.8M | -22.2% | -25.3% |
| MDP | Medexus Pharmaceuticals Inc. | TSX | C$157.9M | +12.7% | +101.9% |
The app has the price chart, every filing, private raises and the full peer set for GRIN.
Open in the app